stock
GlaxoSmithKline PLC ADR
NYSE | GSK
39.16
USD
+0.00 ( +0.00%)
AT CLOSE (AS OF Apr 29, 2025)
$76B
MARKET CAP
22.68
P/E Ratio
1.65
EPS
$44
52 Week High
$31
52 Week Low
LIFE SCIENCES
Sector
GSK Chart
1D
Area
Trade Smarter
Automate your trading workflow with powerful tools — built for serious traders.
GSK Technicals
GSK Earnings
Yearly Income Statement (As of Dec 31, 2024)
| Field | Value (GBP) |
|---|---|
| Gross Profit | $22B |
| Total Revenue | $31B |
| Cost Of Revenue | $9B |
| Costof Goods And Services Sold | $9B |
| Operating Income | $4B |
| Selling General And Administrative | $11B |
| Research And Development | $6.4B |
| Operating Expenses | $18B |
| Investment Income Net | - |
| Net Interest Income | -$603M |
| Interest Income | $60M |
| Interest Expense | $640M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $2.6B |
| Income Before Tax | $3.5B |
| Income Tax Expense | $526M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | $3B |
| Comprehensive Income Net Of Tax | - |
| Ebit | $4.1B |
| Ebitda | $6.7B |
| Net Income | $2.6B |
Revenue & Profitability
Earnings Performance
GSK Financials
yearly Balance Sheet (As of Dec 31, 2024)
| Field | Value (GBP) |
|---|---|
| Total Assets | $59B |
| Total Current Assets | $17B |
| Cash And Cash Equivalents At Carrying Value | $3.7B |
| Cash And Short Term Investments | $3.7B |
| Inventory | $5.7B |
| Current Net Receivables | - |
| Total Non Current Assets | $42B |
| Property Plant Equipment | - |
| Accumulated Depreciation Amortization Ppe | - |
| Intangible Assets | $16B |
| Intangible Assets Excluding Goodwill | $16B |
| Goodwill | $7B |
| Investments | - |
| Long Term Investments | - |
| Short Term Investments | $21M |
| Other Current Assets | $1.6B |
| Other Non Current Assets | - |
| Total Liabilities | $46B |
| Total Current Liabilities | $22B |
| Current Accounts Payable | - |
| Deferred Revenue | - |
| Current Debt | - |
| Short Term Debt | $2.3B |
| Total Non Current Liabilities | $25B |
| Capital Lease Obligations | $1.1B |
| Long Term Debt | $14B |
| Current Long Term Debt | $2.2B |
| Long Term Debt Noncurrent | - |
| Short Long Term Debt Total | $17B |
| Other Current Liabilities | $15B |
| Other Non Current Liabilities | $6.1B |
| Total Shareholder Equity | $14B |
| Treasury Stock | - |
| Retained Earnings | $7.8B |
| Common Stock | $1.3B |
| Common Stock Shares Outstanding | $2.1B |
yearly Cash Flow (As of Dec 31, 2024)
| Field | Value (GBP) |
|---|---|
| Operating Cashflow | $6.6B |
| Payments For Operating Activities | - |
| Proceeds From Operating Activities | - |
| Change In Operating Liabilities | - |
| Change In Operating Assets | - |
| Depreciation Depletion And Amortization | $2.6B |
| Capital Expenditures | $3B |
| Change In Receivables | - |
| Change In Inventory | -$294M |
| Profit Loss | - |
| Cashflow From Investment | - |
| Cashflow From Financing | -$4.7B |
| Proceeds From Repayments Of Short Term Debt | - |
| Payments For Repurchase Of Common Stock | - |
| Payments For Repurchase Of Equity | - |
| Payments For Repurchase Of Preferred Stock | - |
| Dividend Payout | $2.4B |
| Dividend Payout Common Stock | $2.4B |
| Dividend Payout Preferred Stock | - |
| Proceeds From Issuance Of Common Stock | - |
| Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
| Proceeds From Issuance Of Preferred Stock | - |
| Proceeds From Repurchase Of Equity | - |
| Proceeds From Sale Of Treasury Stock | - |
| Change In Cash And Cash Equivalents | - |
| Change In Exchange Rate | - |
| Net Income | $3B |
yearly Income Statement (As of Dec 31, 2024)
| Field | Value (GBP) |
|---|---|
| Gross Profit | $22B |
| Total Revenue | $31B |
| Cost Of Revenue | $9B |
| Costof Goods And Services Sold | $9B |
| Operating Income | $4B |
| Selling General And Administrative | $11B |
| Research And Development | $6.4B |
| Operating Expenses | $18B |
| Investment Income Net | - |
| Net Interest Income | -$603M |
| Interest Income | $60M |
| Interest Expense | $640M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $2.6B |
| Income Before Tax | $3.5B |
| Income Tax Expense | $526M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | $3B |
| Comprehensive Income Net Of Tax | - |
| Ebit | $4.1B |
| Ebitda | $6.7B |
| Net Income | $2.6B |
Dividends
| Field | Value |
|---|---|
| Ex Dividend Date | 2025-02-21 |
| Declaration Date | 2025-02-05 |
| Record Date | 2025-02-21 |
| Payment Date | 2025-04-10 |
| Amount | 0.400652 |
GSK News
GSK Profile
GlaxoSmithKline PLC ADR Profile
Sector: LIFE SCIENCES
Industry: PHARMACEUTICAL PREPARATIONS
GlaxoSmithKline plc is dedicated to the creation, discovery, development, manufacture and marketing of pharmaceuticals, vaccines, over-the-counter drugs and health-related consumer products in the UK, US and internationally. The company is headquartered in Brentford, the United Kingdom.
LGMK 48.06%
$0.0191
DMN 8.57%
$0.0038
WW 88.85%
$0.7809
PTPI -78.07%
$0.0127
GNLN 3.33%
$0.0124
BON 19.85%
$0.0779
AGMH -23.73%
$0.1022
PLUG -5.91%
$0.9597
SOFI 1.70%
$13.4244
DGLY 22.86%
$0.0387
HIMS 26.05%
$35.9004
NVDA 0.92%
$109.73
CYCC 6.45%
$0.3037
TSLA 0.12%
$286.2319
F -0.20%
$10.02
OMH 46.75%
$2.979
PFE 3.18%
$23.7822
AMCR -2.70%
$9.37
PLTR 0.59%
$115.33
LYT -16.78%
$0.0982
LCID 0.79%
$2.55
DNN -3.07%
$1.4152
SNAP 3.85%
$9.17
AAL -0.36%
$9.8148
WLDS 41.23%
$1.6948
INTC 0.44%
$20.5993
ABEV 2.58%
$2.5543
NIO -1.45%
$4.2476
JBLU 3.08%
$4.1953
RIOT -2.43%
$7.4448
RIG -3.90%
$2.22
MARA 2.14%
$14.31
NVNI 20.59%
$0.1868
AMZN -0.09%
$187.5347
ME -21.26%
$0.6063
CUTR -10.19%
$0.0969
BBD 1.67%
$2.43
BTE -2.71%
$1.615
AGNC 0.44%
$9.0599
WULF -2.48%
$2.945
ERIC 0.91%
$8.315
TLRY 2.26%
$0.4877
SAG 42.57%
$1.44
ONCO -8.88%
$0.0729
CCL -1.09%
$18.6535
QBTS -4.14%
$7.065
AZUL -1.15%
$0.8699
APLD -3.90%
$4.5263
HOOD 0.32%
$49.0858
SMCI -1.97%
$36.537
NGD -0.59%
$3.37
LYG 0.63%
$3.985
AAPL 0.59%
$211.3788
GOOGL -0.28%
$160.16
FNA 0.00%
$13.09
BTG 0.32%
$3.1
TGB 3.95%
$2.37
OMEX 14.06%
$1.5056
PONY -8.28%
$9.465
WBD 1.07%
$8.7932
BAC 0.54%
$39.995
GRAB 1.37%
$4.8252
EJH -2.24%
$0.8995
WFC 2.60%
$71.2345
GM -1.13%
$46.7074
RGTI -2.93%
$8.95
ITUB 1.21%
$6.285
LFMD 33.28%
$8.13
AUR 5.52%
$7.26
VALE 0.20%
$9.6191
IXHL -75.46%
$0.1497
IQ 0.00%
$1.89
ACHR 2.81%
$8.7701
PYPL 1.63%
$65.9877
AEG -0.15%
$6.52
CLSK -0.29%
$8.545
PBR 0.56%
$11.575
AG 0.19%
$6.2521
IBIO 10.00%
$1.155
OCEA -22.17%
$0.0066
AREB 0.63%
$3.3509
SPRB -39.45%
$0.0786
T 0.31%
$27.345
STLA 2.54%
$9.5974
VRN -1.37%
$6.105
RIVN 0.72%
$13.285
ABEO -2.06%
$5.24
VOD 0.05%
$9.575
AMD 0.56%
$96.93
KVUE 0.43%
$23.11
FUBO 0.48%
$3.145
HLN 0.44%
$10.275
TMC -2.08%
$3.241
TVGN 14.68%
$1.075
CDE -3.07%
$5.525
BCS 0.98%
$16.127
NCLH -0.63%
$17.33
AVTR 2.06%
$12.7469
GOOG -0.10%
$162.26
HTZ -13.32%
$7.3765
LGMK 48.06%
$0.0191
DMN 8.57%
$0.0038
WW 88.85%
$0.7809
PTPI -78.07%
$0.0127
GNLN 3.33%
$0.0124
BON 19.85%
$0.0779
AGMH -23.73%
$0.1022
PLUG -5.91%
$0.9597
SOFI 1.70%
$13.4244
DGLY 22.86%
$0.0387
HIMS 26.05%
$35.9004
NVDA 0.92%
$109.73
CYCC 6.45%
$0.3037
TSLA 0.12%
$286.2319
F -0.20%
$10.02
OMH 46.75%
$2.979
PFE 3.18%
$23.7822
AMCR -2.70%
$9.37
PLTR 0.59%
$115.33
LYT -16.78%
$0.0982
LCID 0.79%
$2.55
DNN -3.07%
$1.4152
SNAP 3.85%
$9.17
AAL -0.36%
$9.8148
WLDS 41.23%
$1.6948
INTC 0.44%
$20.5993
ABEV 2.58%
$2.5543
NIO -1.45%
$4.2476
JBLU 3.08%
$4.1953
RIOT -2.43%
$7.4448
RIG -3.90%
$2.22
MARA 2.14%
$14.31
NVNI 20.59%
$0.1868
AMZN -0.09%
$187.5347
ME -21.26%
$0.6063
CUTR -10.19%
$0.0969
BBD 1.67%
$2.43
BTE -2.71%
$1.615
AGNC 0.44%
$9.0599
WULF -2.48%
$2.945
ERIC 0.91%
$8.315
TLRY 2.26%
$0.4877
SAG 42.57%
$1.44
ONCO -8.88%
$0.0729
CCL -1.09%
$18.6535
QBTS -4.14%
$7.065
AZUL -1.15%
$0.8699
APLD -3.90%
$4.5263
HOOD 0.32%
$49.0858
SMCI -1.97%
$36.537
NGD -0.59%
$3.37
LYG 0.63%
$3.985
AAPL 0.59%
$211.3788
GOOGL -0.28%
$160.16
FNA 0.00%
$13.09
BTG 0.32%
$3.1
TGB 3.95%
$2.37
OMEX 14.06%
$1.5056
PONY -8.28%
$9.465
WBD 1.07%
$8.7932
BAC 0.54%
$39.995
GRAB 1.37%
$4.8252
EJH -2.24%
$0.8995
WFC 2.60%
$71.2345
GM -1.13%
$46.7074
RGTI -2.93%
$8.95
ITUB 1.21%
$6.285
LFMD 33.28%
$8.13
AUR 5.52%
$7.26
VALE 0.20%
$9.6191
IXHL -75.46%
$0.1497
IQ 0.00%
$1.89
ACHR 2.81%
$8.7701
PYPL 1.63%
$65.9877
AEG -0.15%
$6.52
CLSK -0.29%
$8.545
PBR 0.56%
$11.575
AG 0.19%
$6.2521
IBIO 10.00%
$1.155
OCEA -22.17%
$0.0066
AREB 0.63%
$3.3509
SPRB -39.45%
$0.0786
T 0.31%
$27.345
STLA 2.54%
$9.5974
VRN -1.37%
$6.105
RIVN 0.72%
$13.285
ABEO -2.06%
$5.24
VOD 0.05%
$9.575
AMD 0.56%
$96.93
KVUE 0.43%
$23.11
FUBO 0.48%
$3.145
HLN 0.44%
$10.275
TMC -2.08%
$3.241
TVGN 14.68%
$1.075
CDE -3.07%
$5.525
BCS 0.98%
$16.127
NCLH -0.63%
$17.33
AVTR 2.06%
$12.7469
GOOG -0.10%
$162.26
HTZ -13.32%
$7.3765
Discover more tools and features to empower your trading
Explore FeaturesQuotes and other market data may be delayed by 15 minutes or more. Financial data is provided by financial exchanges and other content providers and may be delayed as specified by financial exchanges or other data providers. AfterPullback does not verify any data and disclaims any obligation to do so. The information contained on this website is not intended as, and shall not be understood as, financial advice. The website does not operated by attorney, accountant or financial advisor and the information contained on this website is not a substitute for financial advice from a professional who is aware of the facts and circumstances of your individual situation. Nothing available on or through this website should be understood as a recommendation that you should not consult with a financial professional to address your particular information.